Other
Preferred Stock, Shares Outstanding
Bristol-Myers Squibb Preferred Stock, Shares Outstanding decreased by 12.5% to 2.5K in Q4 2025 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
Changes in outstanding shares indicate capital issuance or redemption activities, impacting dividend obligations and capital structure.
Detailed definition
The total number of preferred stock shares currently held by shareholders. This reflects the actual amount of preferred...
Peer comparison
Standard equity disclosure for all publicly traded financial institutions.
Metric ID:
other_preferred_stock_shares_outstandingHistorical Data
2 periods
| Q4 '24 | Q4 '25 | |
|---|---|---|
| Value | 2.9K | 2.5K |
| QoQ Change | — | -12.5% |
| YoY Change | — | -12.5% |
Range2.5K – 2.9K
Avg YoY Growth-12.5%
Median YoY Growth-12.5%
Preferred Stock, Shares Outstanding at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's preferred stock, shares outstanding?
- Bristol-Myers Squibb (BMY) reported preferred stock, shares outstanding of 2.5K in Q4 2025.
- What does preferred stock, shares outstanding mean?
- The number of preferred shares currently held by investors.